PDCD1 and atherosclerosis: Comparable to PD-1/PD-L1, CTLA-4 knockout mice show increased lesion size, and mice receiving anti-CTLA-4 blocking antibodies showed increased progression of atherosclerosis mainly driven by T-cell-induced inflammation (Figure 1A) (Poels et al., 2020).